Related Experiment Video
Updated: Jul 18, 2026

Advanced Glycation End-Products Sensitize Human Sensory-Like Neuron Cells to Capsaicin-Induced Calcium Influx
Published on: May 2, 2025
Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress
Andrea M Vincent1, Lorena Perrone, Kelli A Sullivan
1Department of Neurology, Room 5017 BSRB, University of Michigan, 109 Zina Pitcher Place, Ann Arbor, Michigan 48109, USA. andreav@umich.edu
Abstract:
The receptor for advanced glycation end products (RAGE) may promote diabetic vascular and renal disease through the activation of intracellular signaling pathways that promote oxidative stress. Oxidative stress is a mediator of hyperglycemia-induced cell injury and a unifying theme for all mechanisms of diabetic complications, but there are few studies on the expression and potential contribution of RAGE in diabetic neuropathy. The current study demonstrates that dorsal root ganglia neurons express functional RAGE and respond to the RAGE ligand S100 with similar downstream signaling, oxidative stress, and cellular injury as other diabetic complication-prone tissues. RAGE-induced phosphatidylinositol-3 kinase activity is associated with formation of reactive oxygen species, caspase-3 activation, and nuclear DNA degradation. These events are prevented by treatment with the antioxidant alpha-lipoic acid. Our data indicate that therapies aimed at decreasing RAGE ligands, blocking RAGE signaling, or preventing oxidative stress could significantly decrease the development of neuropathy in diabetic patients.
Insights
The receptor for advanced glycation end products (RAGE) is present in nerve cells and contributes to diabetic neuropathy by increasing oxidative stress. Therapies targeting RAGE or oxidative stress may prevent nerve damage in diabetes.
Area of Science:
- Neuroscience
- Endocrinology
- Molecular Biology
Background:
- The receptor for advanced glycation end products (RAGE) is implicated in diabetic vascular and renal complications via oxidative stress pathways.
- Limited research exists on RAGE expression and its role in diabetic neuropathy, a common complication of diabetes.
Purpose of the Study:
- To investigate the presence and function of RAGE in dorsal root ganglia neurons.
- To determine if RAGE activation in neurons contributes to oxidative stress and cellular injury relevant to diabetic neuropathy.
Main Methods:
- Demonstrated functional RAGE expression in dorsal root ganglia neurons.
- Exposed neurons to the RAGE ligand S100 to assess downstream signaling, oxidative stress, and cellular injury.
- Evaluated the effect of the antioxidant alpha-lipoic acid on RAGE-mediated events.
Main Results:
- Dorsal root ganglia neurons express functional RAGE and exhibit downstream signaling, oxidative stress, and cellular injury upon S100 stimulation.
- RAGE activation led to increased reactive oxygen species, caspase-3 activation, and DNA degradation.
- Alpha-lipoic acid treatment effectively prevented these RAGE-induced cellular damages.
Conclusions:
- RAGE signaling in neurons contributes to oxidative stress and cellular injury, suggesting a role in diabetic neuropathy development.
- Therapeutic strategies targeting RAGE ligands, RAGE signaling blockade, or oxidative stress prevention show promise for treating diabetic neuropathy.
Related Concept Videos
Diabetic Neuropathy
Secondary Spinal Cord Injury llI: Pathophysiology
Cellular Injury I: Introduction
Diabetic Nephropathy
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
GPCRs Regulate Adenylyl Cylase Activity
Two...